Essential Information on Investing in Northrop Grumman (NOC)

By Naomi Wentworth • Friday, April 25 15:08 • Permanent Link

Northrop Grumman logged a 1.7% change during today's afternoon session, and is now trading at a price of $470.96 per share. The S&P 500 index moved 1.0%. NOC's trading volume is 772,740 compared to the stock's average volume of 1,188,011.

Northrop Grumman trades -12.91% away from its average analyst target price of $540.78 per share. The 23 analysts following the stock have set target prices ranging from $463.83 to $620.0, and on average have given Northrop Grumman a rating of buy.

Anyone interested in buying NOC should be aware of the facts below:

Northrop Grumman's current price is 83.1% above its Graham number of $257.27, which implies that at its current valuation it does not offer a margin of safety
Northrop Grumman has moved -3.6% over the last year, and the S&P 500 logged a change of 7.5%
Based on its trailing earnings per share of 25.33, Northrop Grumman has a trailing 12 month Price to Earnings (P/E) ratio of 18.6 while the S&P 500 average is 29.3
NOC has a forward P/E ratio of 16.8 based on its forward 12 month price to earnings (EPS) of $28.06 per share
Its Price to Book (P/B) ratio is 4.53 compared to its sector average of 3.2
Northrop Grumman Corporation operates as an aerospace and defense technology company in the United States, the Asia/Pacific, Europe, and internationally.
Based in Falls Church, the company has 97,000 full time employees and a market cap of $67.78 Billion. Northrop Grumman currently returns an annual dividend yield of 1.8%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.